MEG3 and hepatocellular carcinoma: The DNA methylation status of MEG3 affects its expression in human leukocytes [94], and therefore, miR-29-mediated suppression of the DNA methyltransferases DNMT1 and DNMT3b elevates the expression of MEG3, as demonstrated in hepatocellular cancer [95].